2023 Form 5500 filing — U.S. Roche Transitional Benefits Plan

Plain-English filing summary

According to public Form 5500 filings published through the U.S. Department of Labor (DOL) Employee Benefits Security Administration (EBSA) via the EFAST2 system, this is the 2023 Form 5500 filing (EFAST2 acknowledgement 20241014200849NAL0045845440001) for U.S. Roche Transitional Benefits Plan, reported by Genentech, Inc. under EIN 94-2347624 and plan number 515. It reports 22,946 participants. Attached schedule details are not reported in the loaded dataset.

Form 5500 2 · 2023

Filing snapshot

Net assets (EOY)Not reported
Participants22.9K22,946
Provider compensationNone reported
Schedules filedNoneLoaded schedules
EFAST2 acknowledgement
20241014200849NAL0045845440001
Plan sponsor
Genentech, Inc.
EIN
94-2347624
Plan number
515
Location
South San Francisco, CA
Received date
not reported in the loaded dataset
2023

Reported financial snapshot

Reported figures as filed, in whole dollars. Only fields the filing reports are shown.

This 2023 filing is loaded, but detailed Schedule H/I financial figures are not present for it in the current loaded dataset. Participant counts and filing identity above are reported; asset and contribution detail comes from the financial schedules where filed.

Related Form 5500 pages